In addition, ketamine elevates extracellular glutamate levels in the PFC and HIP, while enhancing synaptic connectivity via activation of the BDNF-TrkB pathway, thereby mitigating the degenerative changes linked to depression [133,134]. The gene discussed is BDNF; the disease is depressive disorder.